OTC and Alzheimer disease: In addition, ornithine transcarbamylase was reported to be elevated in the CSF of AD patients (Bensemain et al., 2009) and despite the detection of the remaining urea-cycle enzymes in AD brain tissue, only Arginase 2 was found to be increased (Hansmannel et al., 2010).